Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of DNA damage and repair in liver cancer
Rhys Gillman, Kylie Lopes Floro, Miriam Wankell, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1875, Iss. 1, pp. 188493-188493
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

The role of lncRNA NEAT1 in human cancer chemoresistance
Feng Long, Xue Li, Jingyu Pan, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 10
Advances in Anti-Cancer Activities of Flavonoids in Scutellariae radix: Perspectives on Mechanism
Yiqing Gu, Qi Zheng, Guifang Fan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11042-11042
Open Access | Times Cited: 25
Anti-tumor pharmacology of natural products targeting mitosis
Manru Huang, Caiyan Liu, Yingying Shao, et al.
Cancer Biology and Medicine (2022) Vol. 19, Iss. 6, pp. 1-28
Open Access | Times Cited: 23
Novel roles of PIWI proteins and PIWI-interacting RNAs in human health and diseases
Zeyu Wu, Xiao Yu, Shuijun Zhang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular Repair
Yousef Khazaei Monfared, Pedram Heidari, Samuel J. Klempner, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2761-2761
Open Access | Times Cited: 14
Early Steps of Hepatitis B Life Cycle: From Capsid Nuclear Import to cccDNA Formation
João Diogo Dias, Nazim Sarica, Christine Neuveut
Viruses (2021) Vol. 13, Iss. 5, pp. 757-757
Open Access | Times Cited: 31
Hepatocytes and Hepatic Stellate Cells Carry Different Levels of DNA Damage due to Their Sensitivity to Oxidative Stress in Chronic Hepatitis B
Yansong Zhang, Daozhong Jin, Hongqiong Zhu, et al.
Journal of Viral Hepatitis (2025) Vol. 32, Iss. 3
Closed Access
PRMT5 attenuates regorafenib-induced DNA damage in hepatocellular carcinoma cells through symmetric dimethylation of RPL14
Wendi Bi, Xiaojuan Sun, Qiuyun Yi, et al.
Journal of Gastrointestinal Oncology (2025) Vol. 16, Iss. 1, pp. 191-208
Open Access
Deficiency of DDI2 suppresses liver cancer progression by worsening cell survival conditions
Keli Liu, Shaofan Hu, Reziyamu Wufuer, et al.
Free Radical Biology and Medicine (2025)
Open Access
The Dilemma of Nuclear Mechanical Forces in DNA Damage and Repair
Imran Ali, Fangning Xu, Peng Qin, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151639-151639
Closed Access
Surface-Enhanced Raman Spectroscopy for Characterization of Blood Serum Samples of Liver Carcinoma Patients Using 100 kDa Filtration Devices
Saima Afzal, Seher Nawabzadi, Haq Nawaz, et al.
Plasmonics (2025)
Closed Access
The Role of DNA Damage and Repair in Idiopathic Pulmonary Fibrosis
Jiahui Zhu, Lexin Liu, Xiaodi Ma, et al.
Antioxidants (2022) Vol. 11, Iss. 11, pp. 2292-2292
Open Access | Times Cited: 18
CD81 suppresses NF-κB signaling and is downregulated in hepatitis C virus expressing cells
Maximilian Bunz, Mona Eisele, Dan Hu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2
DNA damage repair-related gene signature for identifying the immune status and predicting the prognosis of hepatocellular carcinoma
Yongpan Lu, Sen Wang, Tingting Chi, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
A Five-Gene Signature Associated With DNA Damage Repair Molecular Subtype Predict Overall Survival for Hepatocellular Carcinoma
Junyu Huo, Xinyi Fan, Bingxin Qi, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 9
Nanomedicines: intervention in inflammatory pathways of cancer
Firoz Anwar, Salma Naqvi, Saiba Shams, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 3, pp. 1199-1221
Open Access | Times Cited: 4
Moringa oleifera and Autophagy: Evidence from In Vitro Studies on Chaperone-Mediated Autophagy in HepG 2 Cancer Cells
Matlola Bopape, Charlette Tiloke, Claudia Ntsapi
Nutrition and Cancer (2023) Vol. 75, Iss. 10, pp. 1822-1847
Open Access | Times Cited: 4
A prominent role of LncRNA H19 in H. pylori CagA induced DNA damage response and cell malignancy
Xiao-Feng He, Tingting Huang, Qinrong Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
The Characteristics and Mortality of Chinese Herbal Medicine Users among Newly Diagnosed Inoperable Huge Hepatocellular Carcinoma (≥10 cm) Patients: A Retrospective Cohort Study with Exploration of Core Herbs
Shuling Chen, Chia-Ying Ho, Wei-Chun Lin, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 19, pp. 12480-12480
Open Access | Times Cited: 7
LINC01419 Promotes the Proliferation of Hepatoma Cells by Recruiting XRCC5 and Regulating Its Phosphorylation to Repair DNA Damage
Pan Liu, Xu Zhang, Qiang Fu, et al.
Disease Markers (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 6
BOP1 Used as a Novel Prognostic Marker and Correlated with Tumor Microenvironment in Pan-Cancer
Wei Li, Peipei Song, Mengyuan Zhao, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-20
Open Access | Times Cited: 7
DNA replication stress stratifies prognosis and enables exploitable therapeutic vulnerabilities of HBV-associated hepatocellular carcinoma: An <i>in-silico</i> precision oncology strategy
Xiaofan Lu, Jialin Meng, Haitao Wang, et al.
The Innovation Medicine (2023) Vol. 1, Iss. 1, pp. 100014-100014
Open Access | Times Cited: 2
Development and Validation of Genome Instability-Associated lncRNAs to Predict Prognosis and Immunotherapy of Patients With Hepatocellular Carcinoma
Yifeng Yan, Liang Ren, Yan Liu, et al.
Frontiers in Genetics (2022) Vol. 12
Open Access | Times Cited: 3
PTIP-Associated Protein 1: More Than a Component of the MLL3/4 Complex
Bo Liu, Zhen Li
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 3
Targeting DNA repair to enhance the efficacy of sorafenib in hepatocellular carcinoma
Mahzeiar Samadaei, Daniel Senfter, Sibylle Madlener, et al.
Journal of Cellular Biochemistry (2022) Vol. 123, Iss. 10, pp. 1663-1673
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top